Because phosphorylated STAT3 is frequently upregulated in Ewing sarcoma [8] and PTPRD dephosphorylates STAT3, the role of germline and somatic PTPRD mutations in Ewing sarcoma as well as the implications for IGF-1R targeted therapy warrant exploration. This evidence concerns the gene IGF1R and Ewing sarcoma.